hexamethylene bisacetamide has been researched along with Teratoma in 12 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCue, PA | 2 |
| Gubler, ML | 1 |
| Maffei, L | 1 |
| Sherman, MI | 3 |
| Matthaei, KI | 1 |
| Taketo, M | 1 |
| Schindler, J | 1 |
| Hollingsworth, R | 1 |
| Coughlin, P | 1 |
| Speers, WC | 1 |
| Birdwell, CR | 1 |
| Dixon, FJ | 1 |
| Tanaka, T | 1 |
| Kimura, H | 2 |
| Sekiya, S | 2 |
| Kawata, M | 2 |
| Takamizawa, H | 2 |
| Yamazawa, K | 1 |
| Shirasawa, H | 1 |
| Astigiano, S | 1 |
| Barkai, U | 1 |
| Abarzua, P | 1 |
| Tan, SC | 1 |
| Harper, MI | 1 |
| Andrews, PW | 2 |
| Nudelman, E | 1 |
| Hakomori, S | 1 |
| Fenderson, BA | 1 |
| Gönczöl, E | 1 |
| Plotkin, SA | 1 |
| Dignazio, M | 1 |
| Oosterhuis, JW | 1 |
| Segal, S | 1 |
| Dmitrovsky, E | 1 |
| Paez de la Cadena, M | 1 |
| Tsung, HC | 1 |
| Chen, ZK | 1 |
| Yao, Z | 1 |
12 other studies available for hexamethylene bisacetamide and Teratoma
| Article | Year |
|---|---|
Complementation analyses of differentiation-defective embryonal carcinoma cells.
Topics: Acetamides; Animals; Antigens, Surface; Carrier Proteins; Cell Differentiation; Cell Line; Embryonal | 1984 |
Differentiation-defective mutants of mouse embryonal carcinoma cells: response to hexamethylenebisacetamide and retinoic acid.
Topics: Acetamides; Animals; Carrier Proteins; Cell Differentiation; Cell Line; Mice; Mutation; Plasminogen | 1983 |
Inducer-dependent phenotypic divergence in an embryonal-carcinoma cell line.
Topics: Acetamides; Animals; Antigens, Neoplasm; Blastocyst; Cell Differentiation; Cell Line; Mice; Phenotyp | 1984 |
Chemically induced bidirectional differentiation of embryonal carcinoma cells in vitro.
Topics: Acetamides; Antigens, Surface; Cell Differentiation; Cell Line; Cell Membrane; Cytoplasm; Diamines; | 1979 |
[Changes in various differentiation-related makers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide (HMBA)].
Topics: Acetamides; Antigens, Surface; Cell Differentiation; Humans; Teratoma; Tumor Cells, Cultured | 1992 |
[Changes in various differentiation-related markers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide].
Topics: Acetamides; Antibodies, Monoclonal; Antigens, Surface; Binding Sites; Cell Differentiation; HLA Anti | 1991 |
[Fundamental studies on differentiation inducers using a human embryonal carcinoma model].
Topics: Acetamides; Animals; Cell Transformation, Neoplastic; DNA, Neoplasm; Humans; Karyotyping; Mice; Mode | 1991 |
Changes in gene expression following exposure of nulli-SCCl murine embryonal carcinoma cells to inducers of differentiation: characterization of a down-regulated mRNA.
Topics: Acetamides; Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Cell Differentiation; C | 1991 |
Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
Topics: Acetamides; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; Bio | 1990 |
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
Topics: Acetamides; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Cisplatin; | 1986 |
The effect of a transfected c-myc proto-oncogene on cellular differentiation.
Topics: Acetamides; Animals; Cell Differentiation; Cell Line; Humans; Leukemia, Erythroblastic, Acute; Mice; | 1988 |
[Phenotype transition of B 7-2 embryonal carcinoma cells during induced differentiation with hexamethylenebisacetamide].
Topics: Acetamides; Animals; Cell Differentiation; Cell Line; Embryonal Carcinoma Stem Cells; Embryonic Indu | 1986 |